Upgrade to SI Premium - Free Trial

NovoCure Ltd. (NVCR) PT Raised to $28 at Mizuho Securities Citing Potential for CMS Reimbursement Approval

February 23, 2018 4:44 AM
Mizuho Securities raised its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles